For example, HGF has been identified as an essential factor in the CAF-mediated resistance to lapatinib in HER2+ breast cancer [69]; and CAFs may also act as a physical barrier against anti-tumor drugs and decrease their availability to tumor cells. The gene discussed is ERBB2; the disease is breast carcinoma.